| Literature DB >> 26257173 |
Marianne Goodwin1, Apoorva Mohan1, Ranjan Batra1, Kuang-Yung Lee2, Konstantinos Charizanis3, Francisco José Fernández Gómez4, Sabiha Eddarkaoui4, Nicolas Sergeant4, Luc Buée4, Takashi Kimura5, H Brent Clark6, Joline Dalton6, Kenji Takamura6, Sebastien M Weyn-Vanhentenryck7, Chaolin Zhang7, Tammy Reid1, Laura P W Ranum1, John W Day8, Maurice S Swanson9.
Abstract
For some neurological disorders, disease is primarily RNA mediated due to expression of non-coding microsatellite expansion RNAs (RNA(exp)). Toxicity is thought to result from enhanced binding of proteins to these expansions and depletion from their normal cellular targets. However, experimental evidence for this sequestration model is lacking. Here, we use HITS-CLIP and pre-mRNA processing analysis of human control versus myotonic dystrophy (DM) brains to provide compelling evidence for this RNA toxicity model. MBNL2 binds directly to DM repeat expansions in the brain, resulting in depletion from its normal RNA targets with downstream effects on alternative splicing and polyadenylation. Similar RNA processing defects were detected in Mbnl compound-knockout mice, highlighted by dysregulation of Mapt splicing and fetal tau isoform expression in adults. These results demonstrate that MBNL proteins are directly sequestered by RNA(exp) in the DM brain and introduce a powerful experimental tool to evaluate RNA-mediated toxicity in other expansion diseases.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26257173 PMCID: PMC4545389 DOI: 10.1016/j.celrep.2015.07.029
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423